Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 20, 2019 - Issue 17
Submit an article Journal homepage
426
Views
6
CrossRef citations to date
0
Altmetric
Review

Pharmacotherapeutic options for biliary tract cancer: current standard of care and new perspectives

Roberto FilippiDepartment of Oncology, University of Turin, Candiolo, Italy;Department of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, ItalyCorrespondence[email protected]
View further author information
,
Pasquale LombardiDepartment of Oncology, University of Turin, Candiolo, Italy;Department of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, ItalyView further author information
,
Virginia QuaràDepartment of Oncology, University of Turin, Candiolo, Italy;Department of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, ItalyView further author information
,
Elisabetta FenocchioMultidisciplinary Outpatient Oncology Clinic, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, ItalyView further author information
,
Giacomo AimarDepartment of Oncology, University of Turin, Candiolo, Italy;Department of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, ItalyView further author information
,
Michela MilanesioDepartment of Oncology, University of Turin, Candiolo, Italy;Department of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, ItalyView further author information
,
Francesco LeoneMedical Oncology, Ospedale degli Infermi, Azienda Sanitaria Locale di Biella, Biella, ItalyView further author information
&
Massimo AgliettaDepartment of Oncology, University of Turin, Candiolo, Italy;Department of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, ItalyView further author information
 show all
Pages 2121-2137 | Received 25 May 2019, Accepted 10 Sep 2019, Published online: 24 Sep 2019

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Roberto Filippi, Francesco Leone, Lorenzo Fornaro, Giuseppe Aprile, Andrea Casadei-Gardini, Nicola Silvestris, Andrea Palloni, Maria Antonietta Satolli, Mario Scartozzi, Marco Russano, Stefania Eufemia Lutrino, Pasquale Lombardi, Giorgio Frega, Silvio Ken Garattini, Caterina Vivaldi, Rosella Spadi, Orsi Giulia, Elisabetta Fenocchio, Oronzo Brunetti, Massimo Aglietta & Giovanni Brandi. (2022) Clinical insights and prognostic factors from an advanced biliary tract cancer case series: a real-world analysis. Journal of Chemotherapy 34:2, pages 123-132.
Read now

Articles from other publishers (5)

Wei Zhang, Junping Shi, Yingying Wang, Hongyuan Zhou, Zewu Zhang, Zhiqiang Han, Guanghao Li, Bo Yang, Guangtai Cao, Yan Ke, Ti Zhang, Tianqiang Song & QiangLi. (2020) Next-generation sequencing-guided molecular-targeted therapy and immunotherapy for biliary tract cancers. Cancer Immunology, Immunotherapy 70:4, pages 1001-1014.
Crossref
Ayhan Ulusakarya, Abdoulaye Karaboué, Oriana Ciacio, Gabriella Pittau, Mazen Haydar, Pamela Biondani, Yusuf Gumus, Amale Chebib, Wathek Almohamad & Pasquale F. Innominato. (2020) A retrospective study of patient-tailored FOLFIRINOX as a first-line chemotherapy for patients with advanced biliary tract cancer. BMC Cancer 20:1.
Crossref
Chiao-En Wu, Wen-Chi Chou, Chia-Hsun Hsieh, John Wen-Cheng Chang, Cheng-Yu Lin, Chun-Nan Yeh & Jen-Shi Chen. (2020) Prognostic and predictive factors for Taiwanese patients with advanced biliary tract cancer undergoing frontline chemotherapy with gemcitabine and cisplatin: a real-world experience. BMC Cancer 20:1.
Crossref
Chiao-En Wu, Yi-Ru Pan, Chun-Nan Yeh & John Lunec. (2020) Targeting P53 as a Future Strategy to Overcome Gemcitabine Resistance in Biliary Tract Cancers. Biomolecules 10:11, pages 1474.
Crossref
Ester Oneda, Mohammed Abu Hilal & Alberto Zaniboni. (2020) Biliary Tract Cancer: Current Medical Treatment Strategies. Cancers 12:5, pages 1237.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.